Navigation Links
Minorities, uninsured less likely to receive care at high-volume hospitals

Compared to white patients, black, Asian and Hispanic patients and those who are uninsured are less likely to undergo complex surgery at high-volume hospitals, which have been associated with better outcomes, according to a study in the October 25 issue of JAMA.

Efforts to improve the quality of surgical care in the United States have led many organizations to advocate the use of high-volume hospitals for certain procedures, since a number of studies have reported of a direct volume-outcome relationship for certain procedures, with patients at high-volume hospitals consistently having better outcomes. It appears there are important differences in the racial and socioeconomic status of patients who receive care at high- and low-volume hospitals, according to background information in the article. These differences may affect the ability to access or receive care at a high-volume hospital.

Jerome H. Liu, M.D., M.S.H.S., of the David Geffen School of Medicine at the University of California-Los Angeles, and colleagues conducted a study to determine whether the use of high-volume hospitals varies by race/ethnicity or insurance status in a broad population of patients undergoing complex surgical care. The researchers examined patient characteristics and use of high-volume hospitals across 10 hospital-based procedures with known volume-outcome relationships among Californians during a 5-year period (2000-2004), collecting data from California's Office of Statewide Health Planning and Development patient discharge database.

The procedures included elective abdominal aortic aneurysm repair, coronary artery bypass grafting, carotid endarterectomy, esophageal cancer resection, hip fracture repair, lung cancer resection, cardiac valve replacement, coronary angioplasty, pancreatic cancer resection, and total knee replacement.

According to this database, a total of 719,608 patients received 1 of the 10 operations. The researchers found that "
'"/>

Source:JAMA and Archives Journals


Page: 1 2

Related biology news :

1. Low oxygen likely made Great Dying worse, greatly delayed recovery
2. FDA: Highly Unlikely Green Tea Lowers Cancer Risk
3. Next good dinosaur news likely to come from small packages
4. Medical experts: US unlikely to have enough vaccines to stop avian flu
5. Parts of the Caribbean and Central America are likely to have less summer rain
6. Access to antiretrovirals unlikely to reduce HIV infection rates
7. Coffee makes us more likely to say yes
8. Farm kids almost twice as likely to die from injury as children overall
9. Ozone recovering, but unlikely to stabilize at pre-1980 levels, says study
10. Tamed 11,400 years ago, figs were likely first domesticated crop
11. Older fathers more likely to have autistic children

Post Your Comments:
(Date:11/6/2009)...FAIRFAX, Va.Registration is now open for the Socie...erventional Oncology (IO) Therapies" Webinar, whic...and transcatheter treatment of liver tumors, kidne... national organization of physicians, scientists a...ing public health through pioneering advances in i...
(Date:11/6/2009)..., DETROIT, Nov. 6 Auburn Hills, ...(LEID) will be installing its locker system and pa...BACS) at the U.S. Department of Health and Human S... in Bethesda, MD. The locker system will support ...for protecting our nation,s medical research agenc...
(Date:11/5/2009)...New Haven, Conn.Researchers at Yale University hav...ng the body,s immune response to HIV and HIV-infec...eir findings, published online in the Journal of ...l therapeutic approaches for these diseases. , ...e targeting HIV" (ARM-H) and "antibody-recruiting ...
Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz CA 5343 1Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz CA 5343 2Mirixa Corporation Announces Key Pharmacy Network Hire 5339 1Mirixa Corporation Announces Key Pharmacy Network Hire 5339 2Newly Updated Pharmacy State Law Compendium Available 5335 1Newly Updated Pharmacy State Law Compendium Available 5335 2
... NYU Langone Medical Center scientists and their ... La Jolla, Calif., have discovered an unexpected c...l meningitis, an infection of the central nervous ...nal Nature. The finding may lead to a new way of t... to viral diseases. , The NYU researchers, Michae...
...adly form of malaria for humans, Plasmodium falci...nzees, this group has been fairly isolated on the ...analysis from the Sackler Institute for Comparativ...ry reveals that malarial parasites found in tree-d...ip with P. falciparum and Plasmodium reichenowi...
...tains, from the Apennines to the Alps, have fascin... Walter Alvarez for more than 35 years, resulting ... that traces Italy,s billion-year geologic history...ndbreaking - and often overlooked - discoveries. ,...n & Company, Inc. Alvarez, a UC Berkeley professor...
Other Biology News:Peering inside the skull of a mouse to solve meningitis mystery 2Peering inside the skull of a mouse to solve meningitis mystery 3African thicket rat malaria linked to virulent human form 2Italy's geologic history becomes a personal tale in Walter Alvarez's new book 2Italy's geologic history becomes a personal tale in Walter Alvarez's new book 3Italy's geologic history becomes a personal tale in Walter Alvarez's new book 4
(Date:11/5/2009)... 5 GenVec, Inc. (Nasdaq:... the third quarter ended September 30, 2009. GenVe...hare) for the three months ended September 30, 200...r share) in the comparable quarter of 2008. For th...et loss was $14.1 million ($0.15 per share), compa...
(Date:11/5/2009)... Nov. 5 ThermoGenesis Co...tive products for processing and storing adult ste...ter of fiscal 2010. ,, For the quarter ended Se... $5.2 million, a 15 percent increase over revenues...The Company said the key contributors to the growt...
(Date:11/5/2009)... 5 Cepheid (Nasdaq: CPH...eaking at the following investor conferences, and ... Credit Suisse Healthcare Conferenc...ber, 2009 at 10 a.m. Mountain Time, ...nd, Tuesday, 1 December, 2009 at 1...
(Date:11/5/2009)...PRNewswire/ -- SpineSmith Partners has signed an i... a unique scaffold that mimics the structure of na...veral commercial products by SpineSmith,s Research...the GenOsteo scaffold represents a significant adv...deal environment for the delivery of adult stem ce...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...ology To Potentially Improve ...7 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) toda...arch and License Agreement with Genentech, Inc. ex...ional targets for potential improvement,of product...nger,DNA-binding protein nuclease (ZFN) technology...
...Group,(Debiopharm), a global independent biopharma...s medical conditions and particularly oncology, to...cology chair at the Ecole,Polytechnique Federale d...,in Oncogenesis. Funded through a CHF 2.5 million ...ge the wide scope of ideas and inventions,discover...
...generate antibodies against novel resea...rmany and ST. LOUIS, Feb. 27 ,Sigma-Aldrich(TM) (N...xchange: MOR; Prime Standard Segment, TecDAX) toda...roduce and distribute unique,recombinant research ...D(R),technology. MorphoSys,s AbD Serotec unit will...
Other Biology Technology:Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production 2Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production 3Debiopharm and EPFL Establish an Oncology Chair 2Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies 2Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies 3
... identified as the cellular homolog of the avian s...been shown to be almost identical to c-Jun in thei...zation and DNA binding, whereas their N-terminal d...vation, diverge. Antigen: The antibody was pro...
Mouse Anti-Yersinia pestis Capsular F1 Antigen Monoclonal Antibody, Unconjugated, Clone YBF19 from QED Bioscience Inc.
Rabbit Anti-JMJD2D Polyclonal Antibody, Unconjugated from Abcam
Perm/Wash Buffer from BD Biosciences Pharmingen
Biology Products: